Afghanistan and Bangladesh Discuss Expanding Bilateral Cooperation in Medicines Regulation

rasooli_admin
Thu, Jan 22 2026 10:54 AM
moph

During his official visit to Bangladesh, Hafiz Dr. Naeemullah Ayoubi, Director General of Drugs and Health Products Regulation of Afghanistan’s Ministry of Public Health, met with Major General Dr. Mohammad Shameem Haidar, Director General of Bangladesh’s Drug Regulatory Authority.

During the meeting, which included technical discussions on bilateral cooperation in medicines, the head of Bangladesh’s drug regulatory authority pledged continued collaboration with Afghanistan. Discussions focused on capacity building for Afghan pharmaceutical personnel, expert visits to Bangladesh and its manufacturing facilities, export of high-quality, low-cost medicines to Afghanistan, and the regulation and registration of medicines and health products.

Discussions were held on speeding up the registration and evaluation of Bangladeshi pharmaceutical companies and products, with an agreement to be signed after technical procedures.

Latest news

Tue, Nov 03 2026 12:04 PM
Background image

Drug Prevention and Public Awareness Program Held for More Than 1200 Students and Teachers at Mahmood Tarzi High School

The program was organized by the Drug Treatment and Awareness officials of Ibn-e-Sina 1,000-Bed Hospital, affiliated with the Ministry of Public Health. Participants received. . .

Tue, Nov 03 2026 11:03 AM
Background image

Two Dental Clinics and Two Diagnostic Centers Shut Down in Helmand Province

Following inspections of 15 private health facilities in Babaji District of Helmand Province, officials from the provincial Monitoring and Inspection Department shut down two dental. . .

Tue, Nov 03 2026 10:59 AM
Background image

Several Key Activities and Achievements of the Ministry of Public Health in Mizan!

Strengthening and Expanding Healthcare Services:

The Ministry of Public Health signed Memorandum of Understanding (MoU) worth more than USD 73 million with the organizations RI, SCI,. . .

BACK TO NEWS